This book is a translation of an original French edition. The translation was done with the help of artificial intelligence. A subsequent human revision was done primarily in terms of content, so that the book will read stylistically differently from a conventional translation.
The book questions what GMOs are, genome editing products and the place of genomic transformations today and tomorrow in our societies. It tries to give some geostrategic and regulatory benchmarks on biotech products in order to better understand the current issues.
The evolution of genome's modification by genetic engineering was characterized by a major technological breakthrough with the discovery of CRISPR in 2012. A distinction is now made between first-generation biotechnologies developed in the 20th century and current second-generation biotechnologies, NGT or New Genomic Techniques, including genome editing. How do we consider these genomic modifications compared to those that occur spontaneously in nature? What are the applications of these techniques in the fields of plants, animals, and human health? What prospects in terms of development and independence for countries and at least what regulations are in force on the different continents?
The book questions what GMOs are, genome editing products and the place of genomic transformations today and tomorrow in our societies. It tries to give some geostrategic and regulatory benchmarks on biotech products in order to better understand the current issues.
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
"Biotech Challenges, Catherine Regnault Roger's latest book, reviews these fast-changing innovations, as New Genomic Techniques (NGTs) such as CRISPR gene editing are being deployed in countries around the world. It is thoughtfully constructed and easily digestible, even for a lay readership; it runs 17 chapters and a concise 150 pages, making it widely accessible to a lay readership. It also includes invaluable bibliographic references." (Michel Thibier, Genetic Literacy Project, geneticliteracyproject.org, June 14, 2024)
"If you want to know more about biotechnology and the perspectives on gene-editing, make sure to check out this new book, called 'Biotech challenges'. It is a key book to understand and follow the ongoing EU debate and the issues surrounding it. The book provides global perspectives of biotech challenges in the world ... ." (seedworld.com, January 31, 2024)
"If you want to know more about biotechnology and the perspectives on gene-editing, make sure to check out this new book, called 'Biotech challenges'. It is a key book to understand and follow the ongoing EU debate and the issues surrounding it. The book provides global perspectives of biotech challenges in the world ... ." (seedworld.com, January 31, 2024)
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826